Answer
As a precaution, breastfeeding should be discontinued during cisatracurium besilate treatment and for at least five elimination half-lives, approximately 3 hours after the last dose or end of infusion.
Sources for this answer
- Cisatracurium 2mg/ml solution for injection/infusionAspen · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 13Document updated
Sources checked